ArticleFrontiers in oncology2025

Cyclophosphamide for severe T-DXd-induced interstitial lung disease in low-HER2 breast cancer: a case report and mechanistic insights.

Weichun Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.